Novus Therapeutics, Inc.
www.novustherapeutics.comNovus Therapeutics, Inc. (NASDAQ: NVUS) is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease.
Read more
Novus Therapeutics, Inc. (NASDAQ: NVUS) is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease.
Read more
Country
State
California
City (Headquarters)
Irvine
Industry
Employees
11-50
Founded
2017
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Member Board of Directors
Email ****** @****.comPhone (***) ****-****
Technologies
(27)
Reach decision makers at Novus Therapeutics, Inc.
Free credits every month!
Novus Therapeutics, Inc. FAQ
Irvine, United States
Biotechnology Research
